Radcliffe Capital Management’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History

Radcliffe Capital Management’s Portfolio SMIH Stock Details SMIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-387,388	Closed	-$3.88M	–	791
2022 Q4	$3.88M	Buy	387,388 +181,582	+88%	+$1.81M	0.12%	263
2022 Q3	$2.02M	Hold	205,806	–	–	0.05%	635
2022 Q2	$2M	Hold	205,806	–	–	0.05%	667
2022 Q1	$2M	Buy	205,806 +5,806	+3%	+$56.2K	0.05%	644
2021 Q4	$1.94M	Hold	200,000	–	–	0.05%	602
2021 Q3	$1.95M	Buy	+200,000	New	+$1.92M	0.06%	487

Radcliffe Capital Management's SMIH Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q1 2023, closing a stake of 387,388 shares — an estimated $3.88M sold.

Radcliffe Capital Management first reported a position in SMIH in Q3 2021 and held it in 6 quarters. The position peaked at $3.88M in Q4 2022. 0 funds tracked by Wall St. Rank hold SMIH as of Q1 2023.

Radcliffe Capital Management reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Radcliffe Capital Management sold 387,388 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $3.88M.
Radcliffe Capital Management first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q3 2021 and held it in 6 quarters.
Radcliffe Capital Management's Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $3.88M in Q4 2022.
0 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.